Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 820 |
---|---|
Genomic Coordinate (GRCh38) | g.22047212G>A |
Variant | c.349+1G>A |
Variant Start Position | 349 |
Location | Intron 3 |
Amino Acid Change | p.? |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Splice donor |
Variant Type | Splicing |
PMID | 16636593, 34806794 |
Article Count | 2 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pvs1, pm2 |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22065330 ref:G alt:A was not found in gnomAD exomes or genomes. |
Variant in Clinvar | Yes |
ClinVar Classification | Pathogenic |
Categories In Literature | - |
No Contrary Evidence Found | TRUE |
ExAC Allele Frequency | 0 |
Thousand Genomes Allel Frequency | 0 |
Ontology Relations | - |
hg19 Mapping Failed | FALSE |
Literature Alleles | X-22065330-G-A |
GnomAD Alleles | - |
DBNSFP Alleles | X-22065330-G-A |
Other Alleles | - |
Note | nan |
Warnings | - |